1-2 of 2
Chris Saddler, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comprehensive Biomarker and Genomic Analysis Identifies p53 Status as the Major Determinant of Response to MDM2 Inhibitors in Chronic Lymphocytic Leukemia.

Sami N. Malek, MD, Peter Ouillette, MT, ASCP, Lisa Kujawski, MD, Sanjeev Shangary, PhD, Moshe Talpaz, MD, Mark Kaminski, MD, Harry Erba, Kerby Shedden, PhD, Shaomeng Wang, PhD, Chris Saddler, BS
Journal: Blood
Blood (2007) 110 (11): 224.
https://doi.org/10.1182/blood.V110.11.224.224
Published: 2007
Journal Articles

Genomic Complexity Identifies Patients with Agressive Chronic Lymphocytic Leukemia.

Sami N. Malek, MD, Peter Ouillette, MT, ASCP, Harry Erba, MD, PhD, Chris Saddler, BS, Andrzej Jakubowiak, MD, Mark Kaminski, MD, Kerby Shedden, PhD, Lisa Kujawski, MD
Journal: Blood
Blood (2007) 110 (11): 489.
https://doi.org/10.1182/blood.V110.11.489.489
Published: 2007